Exenatide manufacturers

Filters

exenatide

Injection 5 mcg/0.02 ml, 10 mcg/0.04 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Registered in
China
Manufacturer #29288

This hi-tech enterprise specializes in the research and manufacturing of diverse peptide products. Founded in 1998, it has become one of the leading peptide pharmaceutical companies globally, offering a full range of services including finished dosage products, APIs, and CRO/CMO services. Their finished dosage products are primarily sold domestically, while APIs have international distribution. The company operates a GMP-certified manufacturing facility exceeding 1500 sq. m., regularly inspected by local and international authorities. They focus on several key therapy areas, employing various principal dosage forms, including peptide-based formulations.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Exenatide is a medication that is used to treat type 2 diabetes. The supplier of exenatide markets it in the form of fast-release as well as extended-release injectable solution preparation kits as well as injectable solutions. The drug was first approved for medical use in 2005 and has since become registered and marketed in over 80 countries worldwide. Exenatide’s manufacturer is Amylin Pharmaceuticals, whereas the commercialization and distribution rights belong to Astra Zeneca (i.e. it is the sole exenatide supplier globally). Given that the supplier’s patent for exenatide is still valid, other manufacturers and vendors have yet to introduce generic or trade name formulations of the drug. The retail prices per 4 injectable solution kits with 2mg powder of exenatide and solvent for an extended-release injectable solution costs approximately 90,00 EUR to 120,00 EUR. Pharmaceutical specialists are welcome to browse through offers of exenatide injectable solution kits for sale from exenatide suppliers and distributors on our pharmaceutical marketplace, or else seek out further useful medical information about the medication online at the official Byetta website.

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.